
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv... MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.21 | 21 | 1 | 1.328 | 0.94 | 891024 | 1.2130598 | CS |
4 | 0.07 | 6.14035087719 | 1.14 | 1.328 | 0.8 | 365647 | 1.12890556 | CS |
12 | 0.09 | 8.03571428571 | 1.12 | 1.5 | 0.8 | 338377 | 1.1948606 | CS |
26 | 0.03 | 2.54237288136 | 1.18 | 2.5591 | 0.8 | 898191 | 1.54760257 | CS |
52 | 0.06 | 5.21739130435 | 1.15 | 5.01 | 0.51 | 1854216 | 2.91322414 | CS |
156 | -5.79 | -82.7142857143 | 7 | 7.9799 | 0.51 | 1285844 | 2.82250068 | CS |
260 | -5.79 | -82.7142857143 | 7 | 7.9799 | 0.51 | 1285844 | 2.82250068 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관